Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | ACACA | Q13085 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3314315 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL13556409 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL19226794 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL23808213 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL22749505 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL24310584 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL23772039 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL23772188 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL21965266 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL5665427 | 1.00 | PTPN1 (0.45) | PTPN1LMNAALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076803-A1 | POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES | INNOVIA, INC. (US) | 2026-03-19 | — | — | US | claimed |
| US-20230167243-A1 | BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2023-06-01 | — | — | US | claimed |
| EP-4136185-A1 | BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME | 3M Innovative Properties Company (US) | 2023-02-22 | — | — | EP | claimed |
| CN-115427532-A | Branched amorphous polyamide (co) polymers and methods of making and using the same | 3M创新有限公司 | 2022-12-02 | — | — | CN | claimed |
| WO-2021209895-A1 | BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-10-21 | — | — | WO | claimed |
| CN-112730291-A | Qualitative and quantitative marker of silkworm counterfeit product and detection method thereof | 江苏省中医院 | 2021-04-30 | — | — | CN | claimed |
| US-5047464-A | Crosslinked polyorthoesters; drug deliver; resilience | MERCK & CO., INC. (US) | 1991-09-10 | — | — | US | claimed |
| EP-0419156-A2 | Bioerodible thermoset elastomers | MERCK & CO. INC. (US) | 1991-03-27 | — | — | EP | claimed |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | CELANESE EVA PERFORMANCE POLYMERS LLC | 2026-04-09 | — | — | US | disclosed |
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260076803-A1 | POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES | INNOVIA, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-12559592-B2 | Branched amorphous polyamide (co)polymers and methods of making and using same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-02-24 | — | — | US | disclosed |
| US-20240199920-A1 | ARTICLES CONTAINING ADHESIVE COMPOSITIONS EXHIBITING ON-DEMAND DEBONDING BEHAVIOR | 3M INNOVATIVE PROPERTIES COMPANY | 2024-06-20 | — | — | US | disclosed |
| US-4180646-A | BIOERODABLE SUSTAINED RELEASE COTAINGS | ALZA CORPORATION (US) | 1979-12-25 | — | — | US | disclosed |
| US-4155992-A | SUSTAINED RELEASE | ALZA CORPORATION (US) | 1979-05-22 | — | — | US | disclosed |
| US-4138344-A | Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4131648-A | POLYMERIC MATERIALS | ALZA CORPORATION (US) | 1978-12-26 | — | — | US | disclosed |
| US-4093709-A | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4079038-A | HAVING RECURRING DIOXYCARBON MOIETIES | ALZA CORPORATION (US) | 1978-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076803-A1 | POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES | TNNC1, TNNI3, MYLK2 | PTPN1 4785/4885LMNA 1033/4885ALDH1A1 1391/4885 |
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | P4HTM, ITGAM, TIMM44 | PTPN1 2486/4885LMNA 3360/4885ALDH1A1 246/4885 |
| US-12559592-B2 | Branched amorphous polyamide (co)polymers and methods of making and using same | COL2A1, PARG, COL1A1 | PTPN1 4243/4885LMNA 383/4885ALDH1A1 1929/4885 |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | GHITM, O60361, P4HTM | PTPN1 1784/4885LMNA 3525/4885ALDH1A1 2350/4885 |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | SAMM50, OPRM1, IRAK4 | PTPN1 774/4885LMNA 3018/4885ALDH1A1 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.